COEPW
Coeptis Therapeutics Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.59
52W High
$0.05
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Coeptis Therapeutics Holdings Inc
Coeptis Therapeutics Holdings Inc is an innovative biotechnology company focused on developing cutting-edge cell and gene therapies for various oncology and rare disease indications. With a robust pipeline driven by proprietary technologies, the firm is poised to address significant unmet medical needs in the healthcare sector. Backed by an experienced management team and strategic collaborations, Coeptis is strategically positioned to make impactful contributions to therapeutic advancements, highlighting its potential for considerable growth in the dynamic biotechnology market.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-23.93M |
| Operating Margin | 0.00% |
| Return on Equity | -1450.00% |
| Return on Assets | -245.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.06 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $12.70M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/10/2026